Peptides Are Exploding. Payments Isn’t Ready
Peptides Are Exploding. Payments Isn’t Ready. The Research-Peptide Market Is Growing Faster Than the Infrastructure Built to Underwrit...
Health Canada issued a health product recall notice on November 12, 2025, for Life Brand Magnesium Bisglycinate 200 mg supplements sold at Shoppers Drug Mart locations nationwide due to an undeclared ingredient. The recall affects all lots of the product manufactured since July 2023, indicating systemic labeling issues spanning more than two years of production.
The recalled product, marketed as containing magnesium bisglycinate—a highly bioavailable form of magnesium—actually contains undeclared magnesium oxide, a different compound with distinct absorption characteristics. Shoppers Drug Mart/Loblaw Companies Limited was listed as the recalling company responsible for the mislabeled dietary supplement sold under the Life Brand private label.
The product carries Natural Product Number (NPN) 80123198, indicating it received Health Canada market authorization as a natural health product. The capsule formulation is marketed as containing 200 mg of elemental magnesium, though the actual form of magnesium differs from what consumers expected based on product labeling.
Health Canada classified this recall as Type III, assigned to situations where use of or exposure to a recalled product is not likely to cause adverse health consequences. Despite the low health risk classification, the agency advises consumers to "consult your health care professional if you have any health concerns" related to the product.
The Type III designation suggests that while the undeclared ingredient constitutes a labeling violation and potentially misleading marketing, health officials do not anticipate serious medical consequences for consumers who used the product. However, the classification does not diminish the regulatory significance of selling supplements containing undeclared ingredients different from those specified on the label.
The recall's scope—covering all lots manufactured since July 2023—raises significant questions about Shoppers Drug Mart/Loblaw Companies Limited's quality control systems and ingredient verification processes. The extended timeline suggests either systematic ingredient substitution, inadequate raw material testing, or failures in finished product verification that persisted for more than 26 months before detection.
For a major pharmacy retailer with a sophisticated supply chain infrastructure, the multi-year period before recall implementation suggests potential gaps in its quality management protocols. The situation highlights challenges facing private-label supplement brands that rely on contract manufacturers and ingredient suppliers to deliver products that meet specifications.
The substitution of magnesium oxide for magnesium bisglycinate has practical implications beyond regulatory compliance. Magnesium bisglycinate is a chelated form of magnesium prized for superior absorption and reduced gastrointestinal side effects compared to other magnesium compounds. Consumers who specifically purchase this premium form may have been paying elevated prices for a product that actually contains the less expensive, less bioavailable magnesium oxide.
Magnesium oxide, while a legitimate dietary supplement ingredient, is known for lower bioavailability and higher likelihood of causing digestive discomfort, particularly at higher doses. Consumers who selected the bisglycinate formulation to avoid these issues may have experienced unexpected effects from the substitution of an undeclared ingredient.
Health Canada provides multiple channels for consumers to report concerns about recalled products or health-related incidents. Consumers can report health or safety incidents related to product use by completing an online consumer product incident report form. For drug or health product side effects or complaints, Health Canada maintains separate reporting mechanisms accessible through its website.
The agency encourages consumers who experienced adverse effects from the recalled magnesium supplement to file reports, which contribute to regulatory surveillance and enforcement priorities. Even in Type III recalls where serious health consequences are not anticipated, consumer reports help regulators understand actual impacts and identify patterns requiring further investigation.
The Health Canada recall highlights differences between Canadian and U.S. approaches to dietary supplement regulation. Canada's Natural Health Products Regulations require pre-market licensing for most supplements sold in the country, with products receiving Natural Product Numbers (NPNs) or Homeopathic Medicine Numbers (DINs) after regulatory review.
This contrasts with the U.S. framework where dietary supplements are not approved by the FDA before marketing, with manufacturers bearing responsibility for ensuring safety and accuracy without pre-market authorization. The Canadian system's pre-market review theoretically provides additional oversight, though this recall demonstrates that authorization does not guarantee ongoing compliance with labeling requirements.
The Life Brand recall exemplifies quality control challenges facing retailers operating private label supplement programs. Major pharmacy chains and grocery retailers increasingly offer house-brand supplements as higher-margin alternatives to national brands, but must rely on contract manufacturers and complex supply chains to deliver products meeting specifications.
Retailers lacking internal quality management capabilities face elevated risk of ingredient substitutions, contamination events, and labeling violations. The two-year period before recall suggests inadequate finished-product testing protocols that would have detected the discrepancy between the labeled and actual ingredients through routine analytical testing.
Effective prevention of ingredient substitution requires comprehensive quality management systems encompassing supplier qualification, raw material testing, in-process controls, and finished product verification. Businesses relying on contract manufacturers must implement robust vendor management programs including:
Companies implementing these protocols can detect ingredient substitutions before products reach consumers, preventing recalls and protecting brand reputation. The Shoppers Drug Mart recall demonstrates the consequences of insufficient quality infrastructure in supplement operations.
For dietary supplement businesses, label accuracy represents more than regulatory compliance—it forms the foundation of consumer trust. When products contain undeclared ingredients or substitute cheaper alternatives for premium compounds, companies breach the fundamental expectation that labels accurately represent contents.
The reputational damage from ingredient substitution recalls can exceed immediate financial costs, particularly for major retailers whose pharmacy operations depend on consumer confidence in product quality. Shoppers Drug Mart's response to this recall and implementation of enhanced quality controls will significantly impact consumer perception of Life Brand supplement reliability.
Health Canada's willingness to issue broad recalls covering extended production periods signals regulatory commitment to supplement label accuracy enforcement. As supplement markets continue expanding and consumers increasingly rely on these products for health maintenance, regulators face mounting pressure to ensure that labels accurately represent contents and that marketing claims align with product formulations.
Businesses operating in the Canadian supplement market should anticipate enhanced scrutiny of ingredient verification protocols, increased regulatory inspections, and potential enforcement actions for labeling violations. Investment in quality management infrastructure that prevents issues before regulatory detection represents the most cost-effective approach to compliance.
Subscribe to Our Newsletter
Stay informed with daily insights on compliance, regulation, and industry trends affecting highly regulated industries.
Subscribe Here
Read Our Blog
Explore in-depth analysis and expert perspectives on navigating the complex regulatory landscape for hemp, CBD, and botanical products.
Visit Our Blog
Reach Out to Learn More About Our Products
Discover how Q-Trust can strengthen your compliance framework, adapt to rapid regulatory changes, and protect your business from federal and state enforcement actions.
Contact Us
